ENDV
ENDONOVO THERAPEUTICS, INC.
Key Financials
Operating Income
$-3264340
↓ 46.6%
Revenue
$135355
↑ 85.2%
Gross Profit
$125365
↑ 115.7%
Net Income
$-18474835
↓ 495.0%
EPS (Diluted)
$0.00
N/A
Total Assets
$1.3M
↓ 36.2%
Shareholders' Equity
$-32180319.00
↓ 104.0%
Cash & Equivalents
$85936.00
↑ 540.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SEC STAFF ACTION | 9/19/2024 | View on SEC |
| 15-12G | 2/2/2024 | View on SEC |
| 8-K | 1/3/2024 | View on SEC |
| 10-Q/A | 12/29/2023 | View on SEC |
| 10-Q | 12/29/2023 | View on SEC |
| 8-K | 12/4/2023 | View on SEC |
| NT 10-Q | 11/15/2023 | View on SEC |
| 8-K | 10/12/2023 | View on SEC |
| 1-A/A | 8/25/2023 | View on SEC |
| 10-Q | 8/21/2023 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENDV |
| Company Name | ENDONOVO THERAPEUTICS, INC. |
| CIK | 1528172 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (800) 489-4774 |